Gaithersburg, MD, United States of America

Wai Keen Chung

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medimmune Limited. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wai Keen Chung. Retrieved from https://idiyas.com/inventor/wai-keen-chung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Wai Keen Chung

Introduction

Wai Keen Chung is an accomplished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of protein manufacturing, particularly in the area of disulfide bond management. His innovative work has led to the development of methods that enhance the stability and functionality of proteins.

Latest Patents

Wai Keen Chung holds 1 patent titled "Prevention of protein disulfide bond reduction." This patent discloses methods for testing the presence and/or activity of glutathione system components and thioredoxin system components during the manufacturing process of disulfide bond-containing proteins. Additionally, it outlines methods for mitigating the reduction of disulfide bonds during manufacturing and for lowering the reduction potential of these proteins. The patent also provides compositions, kits, and methods aimed at diminishing the reduction potential of disulfide bond-containing proteins during protein manufacturing processes.

Career Highlights

Wai Keen Chung is currently associated with MedImmune Limited, where he applies his expertise in protein chemistry and manufacturing. His work at MedImmune has been pivotal in advancing the company's capabilities in biopharmaceutical development.

Collaborations

Wai Keen Chung collaborates with various professionals in his field, including his coworker Sanjeev Ahuja. Their combined efforts contribute to the innovative research and development initiatives at MedImmune.

Conclusion

Wai Keen Chung's contributions to the field of protein manufacturing through his innovative patent demonstrate his commitment to advancing biopharmaceutical technologies. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…